Expanse Stocks

Expanse Stocks

Share this post

Expanse Stocks
Expanse Stocks
Hidden Gems - Special Edition II
Hidden Gems

Hidden Gems - Special Edition II

Uncovering one unusual big-cap hidden gem and one industrial small-cap serial acquirer

Nikotes's avatar
Money Machine Newsletter's avatar
Nikotes
and
Money Machine Newsletter
Mar 19, 2025
∙ Paid
4

Share this post

Expanse Stocks
Expanse Stocks
Hidden Gems - Special Edition II
2
Share

Expanse Stocks x Finchat.io Partnership!

🎁 Get 20% off + 2 months free on any Finchat plan! →📎 Claim Discount

Welcome to the Second Hidden Gems Special Edition!

📰 What’s New at Expanse Stocks?

📊 Quarterly Update - Portfolio Composition (by Industry and Geography) + Valuation Metrics → 🔗 Behind-The-Scenes [Free access]

📚 Articles

🔎 Deep Dive Briefs
⛅ Cloudflare | 👷‍♂️ Parsons | 𓇲 MPS | 🥼 Medpace | 🔌 Arista | 🛒 Amazon | 🤖 ASML | 🦎 Topicus | 💡 Lumine | ✈ HEICO

💸 General Investing
💎 Hidden Gems Series
✨ Annual Specials – Annual Letters, Investing Philosophy & Top Picks of the Year
📚 Resources for Investors
📢 Latest Stock News
💬 Join My Chat → [📎 Learn more]

👀 Recent Releases!

  • 💆‍♂️ A Reflection on my Investing Mistakes

  • 💸 Optionality: Hidden Engine of Long-term Compounding

👀 Coming Soon

  • 💎 Hidden Gem - Fifth Edition

  • 💸 Why Equities Win Against Other Assets


Unlike the standard series, these special editions are exclusive to Paid Subscribers and spotlight under-the-radar businesses that are either part of the Expanse Stocks 📎 Portfolio or high on the long-term Watchlist. These companies stand out for their exceptional business quality, underrated fundamentals, or strong growth potential often supported by compelling technical setups.

For this second Special Edition, we're heading to Switzerland and Sweden to uncover one surprisingly overlooked biopharma powerhouse and one small-cap industrial serial acquirer gem.

1️⃣ A Surprising Undiscovered Healthcare Powerhouse

With a €43B market cap, this high-quality company plays a crucial role in the pharmaceutical supply chain, specializing in third-party drug manufacturing—helping biopharma firms outsource production & process development. I like to think of it as the TSM of Drugs Manufacturing.

I already highlighted this gem in my Monthly Specials - February 2025 (for Paid Subscribers), as it’s forming one of my favorite technical setups—an Inverse Head & Shoulders emerging from a long consolidation phase. The good news? It’s still actionable.

2️⃣ A Small-Cap Serial Acquirer Keeping Sweden’s Factories Running

A $750M small-cap Swedish serial acquirer, specializing in industrial components & services across the Nordic region. With strong management, a winning culture, and solid fundamentals (+15% sustainable revenue growth, 27% ROCE), this high-quality compounder caught my attention—first brought up by REQ Capital, one of the best investment funds in serial acquirers.

Not cheap at Fwd. 35x EV/FCF, but great businesses rarely are.

Topics I’ll Cover

🔹 Founding & Origins
🔹 Industry Trends & Strategy
🔹 Growth Drivers
🔹 Leadership & Culture
🔹 Fun Facts & Golden Nuggets
🔹 Final Thoughts & Technical Setup

Let’s dive in!


➕ Unlock Premium Content – For just $0.39/day ($12/month) or $0.27/day ($100/year)!

📎 Full Portfolio Content - 🗓️ Biweekly Updates (Last Update: 28-June-2025)

  1. 📈 Biweekly Report – Portfolio updates, recent moves & watchlist additions

  2. 💼 Full Portfolio Access – Holdings, valuation metrics & performance tracking

  3. 📊 Valuation Tools – DCF, reverse DCF, capital efficiency & growth models

  4. 🎧 Podcast Picks – Biweekly handpicked episodes on business & investing

  5. 🔎 Stock Picking Framework – My methodology & investing philosophy

  6. 🎯 Swing Trading – Short-term strategy & latest swing trades

  7. 💬 Private Community Chat - 📎 Learn more

  8. 🔐 Full access to all my articles

This post is for paid subscribers

Already a paid subscriber? Sign in
Money Machine Newsletter's avatar
A guest post by
Money Machine Newsletter
The Red Pill of Stock Picking Service & Research.
Subscribe to Money
© 2025 Expanse Stocks
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share